| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, Wisconsin 53792
Address all correspondence and requests for reprints to: Dr. Michael N. Gould, Department of Oncology, K4/334 Clinical Science Center, 600 Highland Avenue, Madison, Wisconsin 53792. E-mail: gould{at}humonc.wisc.edu
The Wistar-Kyoto (WKY) rat strain expresses high levels of ß-casein in its virgin mammary glands. We found that the onset of ß-casein overexpression (BCO) occurs at 6 weeks of age, with morphological differentiation of the mammary gland detectable at 7 weeks of age. BCO was previously shown to be cell autonomous; however, we found that adrenal and ovarian hormones were permissive and necessary for the expression of the BCO phenotype, indicating that the genetic variation that initiates BCO from within the mammary epithelium can only manifest BCO in the presence of virgin hormone levels. Sequencing of the WKY and Wistar-Furth (WF) rat ß-casein promoters showed them to be identical. Culture of primary rat mammary epithelial cells (RMEC) under lactogenic conditions revealed that expression of ß-casein was independent of epidermal growth factor (EGF) in RMEC from virgin WKYv, but was dependent in WFv, RMEC. RMEC from a pregnant WFp responded similarly to WKYv RMEC, suggesting that EGF-independent ß-casein expression occurs naturally in differentiated rat mammary epithelium. However, induction of ß-casein expression in RMEC from immature WKY rats was also independent of EGF, indicating that the induction as well as maintenance of BCO do not require EGF. We suggest that an EGF-independent signaling pathway, arising from a trans-acting inherited effector(s), underlies BCO.
This article has been cited by other articles:
![]() |
M. C. Larsen, P. B. Brake, R. S. Pollenz, and C. R. Jefcoate Linked Expression of Ah Receptor, ARNT, CYP1A1, and CYP1B1 in Rat Mammary Epithelia, in Vitro, Is Each Substantially Elevated by Specific Extracellular Matrix Interactions that Precede Branching Morphogenesis Toxicol. Sci., November 1, 2004; 82(1): 46 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wood, J. E. Korkola, and M. C. Archer Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes Carcinogenesis, January 1, 2002; 23(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lan, C. M. Kendziorski, J. D. Haag, L. A. Shepel, M. A. Newton, and M. N. Gould Genetic Loci Controlling Breast Cancer Susceptibility in the Wistar-Kyoto Rat Genetics, January 1, 2001; 157(1): 331 - 339. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |